Skip to Main Content

Paper Details

Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
Eur Urol
29
2017
Author NameAffiliation
Fred SaadUniversity of Montreal
Dana E RathkopfMemorial Sloan Kettering Cancer Center and Weill Cornell Medical College New York
Johann S de BonoThe Institute of Cancer Research and The Royal Marsden Hospital
Eric J SmallHelen Diller Family Comprehensive Cancer Center, University of California San Francisco
  • 1 - 4

Datasets

Release 1.2